Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – The “dramatic benefits” of probiotic supplements for reducing death and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) preterm neonates have been…
NEW YORK (Reuters Health) – Positron emission tomography (PET) of the liver is extremely unreliable in patients who’ve just had chemotherapy for colorectal cancer metastases, because the false-negative…
NEW YORK (Reuters Health) – During a no-scalpel vasectomy, lidocaine given via a short fine needle provides excellent anesthesia, Canadian and US researchers report in the May issue…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…
NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
NEW YORK (Reuters Health) – Prostate specific antigen (PSA) doubling time as measured before radical prostatectomy does not predict biochemical progression after surgery, according to a report in…
NEW YORK (Reuters Health) – A comparison of 10 seizure drugs in older epilepsy patients shows that lamotrigine is the most effective — based on 12-month retention and…
Get a real-life look at what’s happening on the ground in Haiti from Dr. Pierre Rouzier, Sports Medicine doctor at University of Massachusetts Amherst. In the aftermath of…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
